Martingale Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Buy |
64,793
+7,594
| +13% | +$239K | 0.05% | 301 |
|
|
2025
Q1 | $1.87M | Buy |
57,199
+12,607
| +28% | +$413K | 0.05% | 311 |
|
|
2024
Q4 | $1.61M | Buy |
44,592
+6,796
| +18% | +$246K | 0.04% | 357 |
|
|
2024
Q3 | $1.18M | Buy |
37,796
+1,660
| +5% | +$51.8K | 0.03% | 421 |
|
|
2024
Q2 | $967K | Hold |
36,136
| – | – | 0.02% | 450 |
|
|
2024
Q1 | $1.23M | Hold |
36,136
| – | – | 0.02% | 422 |
|
|
2023
Q4 | $1.05M | Sell |
36,136
-12,000
| -25% | -$347K | 0.02% | 439 |
|
|
2023
Q3 | $1.33M | Hold |
48,136
| – | – | 0.03% | 358 |
|
|
2023
Q2 | $1.45M | Buy |
48,136
+1,901
| +4% | +$57.1K | 0.03% | 346 |
|
|
2023
Q1 | $1.68M | Buy |
46,235
+200
| +0.4% | +$7.25K | 0.03% | 309 |
|
|
2022
Q4 | $1.64M | Sell |
46,035
-2,733
| -6% | -$97.5K | 0.03% | 315 |
|
|
2022
Q3 | $1.65M | Buy |
48,768
+3,800
| +8% | +$129K | 0.03% | 291 |
|
|
2022
Q2 | $1.3M | Buy |
44,968
+2,951
| +7% | +$85.4K | 0.02% | 389 |
|
|
2022
Q1 | $1.36M | Sell |
42,017
-3,755
| -8% | -$121K | 0.02% | 401 |
|
|
2021
Q4 | $1.34M | Buy |
45,772
+36,871
| +414% | +$1.08M | 0.02% | 411 |
|
|
2021
Q3 | $238K | Buy |
+8,901
| New | +$238K | ﹤0.01% | 791 |
|
|
2021
Q2 | – | Sell |
-22,221
| Closed | -$582K | – | 894 |
|
|
2021
Q1 | $582K | Sell |
22,221
-20,127
| -48% | -$527K | 0.01% | 568 |
|
|
2020
Q4 | $1.07M | Sell |
42,348
-15,100
| -26% | -$380K | 0.01% | 425 |
|
|
2020
Q3 | $1.2M | Buy |
57,448
+24,735
| +76% | +$516K | 0.01% | 581 |
|
|
2020
Q2 | $777K | Buy |
+32,713
| New | +$777K | 0.01% | 792 |
|
|
2019
Q1 | – | Sell |
-14,611
| Closed | -$486K | – | 1056 |
|
|
2018
Q4 | $486K | Buy |
14,611
+500
| +4% | +$16.6K | 0.01% | 861 |
|
|
2018
Q3 | $711K | Sell |
14,111
-1,411
| -9% | -$71.1K | 0.01% | 785 |
|
|
2018
Q2 | $929K | Buy |
+15,522
| New | +$929K | 0.01% | 758 |
|
|
2015
Q3 | – | Sell |
-12,912
| Closed | -$220K | – | 883 |
|
|
2015
Q2 | $220K | Buy |
+12,912
| New | +$220K | 0.01% | 822 |
|